Return on Tangible Equity: The amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity. Calculated as: Income from Continuing Operations / Tangible Shareholders Equity
Alaunos Therapeutics, Inc. (TCRT) had Return on Tangible Equity of -101.42% for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
$0.00M |
|
$-1.07M |
|
-- |
|
$0.00M |
|
$1.09M |
|
$-1.09M |
|
$0.02M |
|
$-1.07M |
|
$-1.07M |
|
$-1.07M |
|
$-1.07M |
|
$-1.07M |
|
$-1.07M |
|
$-1.09M |
|
$-1.09M |
|
1.60M |
|
1.60M |
|
$-0.67 |
|
$-0.67 |
|
| Balance Sheet Financials | |
$1.07M |
|
-- |
|
$1.05M |
|
$2.12M |
|
$1.06M |
|
-- |
|
-- |
|
$1.06M |
|
$1.06M |
|
$1.06M |
|
$1.06M |
|
1.60M |
|
| Cash Flow Statement Financials | |
$-0.77M |
|
$0.00M |
|
$0.00M |
|
$1.09M |
|
$0.32M |
|
$-0.77M |
|
$0.07M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.00 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-54600.00% |
|
-54600.00% |
|
-- |
|
-53649.99% |
|
-53649.99% |
|
$-0.77M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
1.00 |
|
90.00 |
|
-101.41% |
|
|
Return on Tangible Equity |
-101.42% |
-50.61% |
|
-101.42% |
|
$0.66 |
|
$-0.48 |
|
$-0.48 |
|